• Trials and Research

  Ocrevus Opposed as PPMS Treatment in UK’s National Health System

  Posted by MS News Today Moderator on July 5, 2018 at 7:57 am

  Click here to learn why NICE, the National Institute for Health and Care Excellence, has decided not to recommend Ocrevus for inclusion within the UK’s National Health Service to treat at low or no cost primary progressive multiple sclerosis in adults: NICE Opposes Ocrevus as PPMS Treatment in UK’s Public-funded Health System

  Do you agree with this decision? Why or why not?

  replied 5 years, 9 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply